Putnam BioRevolution ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SYNB and buy or sell other stocks, ETFs, and their options commission-free!

About SYNB

SYNB actively invests in companies of all sizes around the globe that enable biological innovation. 

SYNB Key Statistics

AUM
AUM
Price-Earnings ratio
32.72
Price-Earnings ratio32.72
30-Day yield
30-Day yield
Average volume
135.80
Average volume135.80
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$31.73
52 Week high$31.73
52 Week low
$24.57
52 Week low$24.57
Expense ratio
Expense ratio

Stock Snapshot

The current Putnam BioRevolution ETF(SYNB) stock price is $31.61, with a market capitalization of 2.37M. The stock trades at a price-to-earnings (P/E) ratio of 32.72 and offers a dividend yield of 77.6%.

During the trading day, Putnam BioRevolution ETF(SYNB) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Putnam BioRevolution ETF(SYNB) stock has reached 0, versus its average volume of 135.8.

Over the past 52 weeks, Putnam BioRevolution ETF(SYNB) stock has traded between a high of $31.73 and a low of $24.57.

Over the past 52 weeks, Putnam BioRevolution ETF(SYNB) stock has traded between a high of $31.73 and a low of $24.57.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.